)

Innoviva (INVA) investor relations material
Innoviva H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Business structure and strategy
Operates a three-part business: respiratory royalty portfolio, critical care/infectious disease therapeutics (IST), and strategic healthcare investments.
Royalty portfolio expected to generate over $1 billion in revenue over the next five years.
IST platform includes four marketed products and one late-stage pipeline candidate, with $130 million in sales and over 50% annual growth.
Strategic healthcare investments valued at approximately $450 million, offering attractive risk-reward profiles.
Focus on capital allocation to high unmet medical needs and long-term value creation.
Financial performance and growth
IST's global product sales grew by over 60% in 2024, driven by GIAPREZA® and XACDURO® launches.
Royalty business continues to outperform analyst expectations, providing stable cash flows.
Over 50% year-on-year growth in US product sales from therapeutics in the first half of the year.
Royalty streams from ANORO® ELLIPTA® and RELVAR®/BREO® ELLIPTA® are resilient and generate significant revenue, especially ex-US.
Both royalty and IST products have patent protection into the 2030s, supporting long-term revenue durability.
Product portfolio and innovation
IST built on differentiated products with strong synergies and a highly experienced team.
GIAPREZA® relaunch supported by new commercial strategy and sales force optimization.
XACDURO® targets acinetobacter infections and has had a highly successful launch.
XERAVA® addresses rising ESBL-mediated resistance; ZEVTERA® launched in the US for Staphylococcus bacteremia.
Zoliflodacin, a late-stage candidate for resistant gonorrhea, has a PDUFA date in mid-December.
Next Innoviva earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage